摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-tert-butoxymalonamic acid ethyl ester | 608520-17-8

中文名称
——
中文别名
——
英文名称
N-tert-butoxymalonamic acid ethyl ester
英文别名
ethyl N-tert-butoxymalonamate;Ethyl 3-(tert-butoxyamino)-3-oxopropanoate;ethyl 3-[(2-methylpropan-2-yl)oxyamino]-3-oxopropanoate
N-tert-butoxymalonamic acid ethyl ester化学式
CAS
608520-17-8
化学式
C9H17NO4
mdl
——
分子量
203.238
InChiKey
MAJPYRUMXCHEAU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.053±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    14
  • 可旋转键数:
    6
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.78
  • 拓扑面积:
    64.6
  • 氢给体数:
    1
  • 氢受体数:
    4

SDS

SDS:6ebd9a02740df1429109ff6fb1747efa
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-tert-butoxymalonamic acid ethyl ester哌啶氢氧化钾 、 sodium cyanoborohydride 、 溶剂黄146 作用下, 以 乙醇乙腈 为溶剂, 反应 27.0h, 生成 N-tert-butoxy-2-(3-phenoxybenzyl)malonamic acid
    参考文献:
    名称:
    针对金属蛋白酶家族的新型异羟肟酸文库:设计,平行合成和筛选。
    摘要:
    我们在此报告基于丙二酸-异羟肟酸模板的217种化合物的设计和平行合成。这些化合物是通过两步溶液阶段法获得的。所使用的各种不同的构建基组使该策略适合于寻找各种金属蛋白酶的抑制剂,并适合于研究新的金属蛋白酶的生物学作用。作为概念证明,我们在中性氨基肽酶(APN; EC 3.4.11.2)(M1家族的原型酶)上筛选了该文库。鉴定了几种亚微摩尔抑制剂。
    DOI:
    10.1016/j.bmc.2006.10.010
  • 作为产物:
    参考文献:
    名称:
    Design, synthesis and antimalarial activity of novel, quinoline-Based, zinc metallo-aminopeptidase inhibitors
    摘要:
    PfA-M1, a neutral zinc aminopeptidase of Plasmodium falciparum, is a new potential target for the discovery of anti-malarials. The design and synthesis of a library of 45 quinoline-based inhibitors of PfA-M1 is reported. The best inhibitor displays an IC50 of 854 nM. The antimalarial activity on a CQ-resistant strain and the specificity towards mammalian aminopeptidase N are also discussed. (C) 2003 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(03)00550-x
点击查看最新优质反应信息

文献信息

  • Pyrido[2,3-d]pyrimidines and their use as kinase inhibitors
    申请人:GPC Biotech Inc.
    公开号:EP1914234A1
    公开(公告)日:2008-04-23
    The present invention provides derivatives of pyrido [2,3-d]pyrimidin-7-one of formula (I). These compounds are kinase inhibitors, including compounds that show anti-proliferative activity, including against tumor cells, and are useful in the treatment of diseases including cancer.
    本发明提供了公式(I)的吡啶并[2,3-d]嘧啶-7-酮衍生物。这些化合物是激酶抑制剂,包括显示抗增殖活性的化合物,包括对肿瘤细胞,对治疗癌症等疾病有用。
  • Structure–Activity Relationships and Blood Distribution of Antiplasmodial Aminopeptidase-1 Inhibitors
    作者:Rebecca Deprez-Poulain、Marion Flipo、Catherine Piveteau、Florence Leroux、Sandrine Dassonneville、Isabelle Florent、Louis Maes、Paul Cos、Benoit Deprez
    DOI:10.1021/jm301506h
    日期:2012.12.27
    Malaria is a severe infectious disease that causes between 655 000 and 1.2 million deaths annually. To overcome the resistance to current drugs, new biological targets are needed for drug development. Aminopeptidase M1 (PfAM1), a zinc metalloprotease, has been proposed as a new drug target to fight malaria. Herein, we disclosed the structure-activity relationships of a selective family of hydroxamate PfAM1 inhibitors based on the malonic template. In particular, we performed a "fluoro-scanning" around hit 1 that enlightened the key positions of the halogen for activity. The docking of the best inhibitor 2 is consistent with in vitro results. The stability of 2 was evaluated in microsomes, in plasma, and toward glutathione. The in vivo distribution study performed with the nanomolar hydroxamate inhibitor 2 (BDM14471) revealed that it reaches its site of action. However, it fails to kill the parasite at concentrations relevant to the enzymatic inhibitory potency, suggesting that killing the parasite remains a challenge for potent and druglike catalytic-site binding PfAM1 inhibitors. In all, this study provides important insights for the design of inhibitors of PfAM1 and the validity of this target.
  • WO2008/150260
    申请人:——
    公开号:——
    公开(公告)日:——
  • Design, synthesis and antimalarial activity of novel, quinoline-Based, zinc metallo-aminopeptidase inhibitors
    作者:Marian Flipo、Isabelle Florent、Philippe Grellier、Christian Sergheraert、Rebecca Deprez-Poulain
    DOI:10.1016/s0960-894x(03)00550-x
    日期:2003.8
    PfA-M1, a neutral zinc aminopeptidase of Plasmodium falciparum, is a new potential target for the discovery of anti-malarials. The design and synthesis of a library of 45 quinoline-based inhibitors of PfA-M1 is reported. The best inhibitor displays an IC50 of 854 nM. The antimalarial activity on a CQ-resistant strain and the specificity towards mammalian aminopeptidase N are also discussed. (C) 2003 Elsevier Ltd. All rights reserved.
  • A library of novel hydroxamic acids targeting the metallo-protease family: Design, parallel synthesis and screening
    作者:Marion Flipo、Terence Beghyn、Julie Charton、Virginie A. Leroux、Benoit P. Deprez、Rebecca F. Deprez-Poulain
    DOI:10.1016/j.bmc.2006.10.010
    日期:2007.1.1
    We report here the design and parallel synthesis of 217 compounds based on a malonic-hydroxamic acid template. These compounds are obtained via a two-step solution-phase procedure. The set of diverse building-blocks used makes this strategy suitable for the search of inhibitors of various metallo-proteases and for the investigation of the biological role of new metallo-proteases. As a proof of concept
    我们在此报告基于丙二酸-异羟肟酸模板的217种化合物的设计和平行合成。这些化合物是通过两步溶液阶段法获得的。所使用的各种不同的构建基组使该策略适合于寻找各种金属蛋白酶的抑制剂,并适合于研究新的金属蛋白酶的生物学作用。作为概念证明,我们在中性氨基肽酶(APN; EC 3.4.11.2)(M1家族的原型酶)上筛选了该文库。鉴定了几种亚微摩尔抑制剂。
查看更多